Microfluidic platform for culturing cells

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a perspective view of a microfluidic platform for culturing cells;

FIG. 2 is a front elevation view thereof;

FIG. 3 is a back elevation view thereof;

FIG. 4 is a top plan view thereof;

FIG. 5 is a bottom plan view thereof;

FIG. 6 is a left elevation view thereof; and,

FIG. 7 is a right elevation view thereof.

Some aspects of the microfluidic platform for culturing cells are shown with symbolic breaks in thickness. The appearance of any portion of the microfluidic platform for culturing cells between the break lines forms no part of the claimed design.

Structures shown in broken lines form no part of the claimed design.

Claims

The ornamental design for a microfluidic platform for culturing cells, as shown and described.

Referenced Cited
U.S. Patent Documents
5358871 October 25, 1994 Stevens
D382974 August 26, 1997 Lahm
D438633 March 6, 2001 Miller
D637733 May 10, 2011 Wei
D730536 May 26, 2015 Mangan
D734482 July 14, 2015 Peterman
D760399 June 28, 2016 So
D841184 February 19, 2019 Viola
D851275 June 11, 2019 Spuhler
D876668 February 25, 2020 Norton
D881409 April 14, 2020 Kayyem
D890360 July 14, 2020 Galen
D910202 February 9, 2021 Chou
D928980 August 24, 2021 Fang
D990333 June 27, 2023 Wu
20130259838 October 3, 2013 Yamanaka et al.
20140038225 February 6, 2014 Goedecke et al.
20140142370 May 22, 2014 Wong et al.
20150087079 March 26, 2015 Coffey
20150251175 September 10, 2015 Briggs
20160346484 December 1, 2016 Abal
20190094208 March 28, 2019 Vuong et al.
20190276784 September 12, 2019 Lin et al.
20200318050 October 8, 2020 Wood et al.
20210402404 December 30, 2021 Gutierrez
20220025309 January 27, 2022 Atic et al.
Foreign Patent Documents
2017025620 February 2017 WO
Other references
  • Andriacchi TP, Mündermann A, Smith RL, Alexander EJ, Dyrby CO, Koo S. A framework for the in vivo pathomechanics of osteoarthritis at the knee. Annals of biomedical engineering. Mar. 2004;32:447-57.
  • Archer CW, McDowell J, Bayliss MT, Stephens MD, Bentley G. Phenotypic modulation in sub-populations of human articular chondrocytes in vitro. Journal of cell science. Oct. 1, 1990;97(2):361-71.
  • Centers for Disease Control and Prevention. Arthritis: How CDC Improves Quality of Life for People With Arthritis. 2020. 2 pages.
  • Collins JA, Arbeeva L, Chubinskaya S, Loeser RF. Articular chondrocytes isolated from the knee and ankle joints of human tissue donors demonstrate similar redox-regulated MAP kinase and Akt signaling. Osteoarthritis and cartilage. Apr. 1, 2019;27(4):703-11.
  • Collins JA, Wood ST, Bolduc JA, Nurmalasari ND, Chubinskaya S, Poole LB, Furdui CM, Nelson KJ, Loeser RF. Differential peroxiredoxin hyperoxidation regulates MAP kinase signaling in human articular chondrocytes. Free Radical Biology and Medicine. Apr. 1, 2019; 134:139-52.
  • Collins JA, Wood ST, Nelson KJ, Rowe MA, Carlson CS, Chubinskaya S, Poole LB, Furdui CM, Loeser RF. Oxidative stress promotes peroxiredoxin hyperoxidation and attenuates pro-survival signaling in aging chondrocytes. Journal of Biological Chemistry. Mar. 25, 2016;291(13):6641-54.
  • Cooke ME, Pearson MJ, Moakes RJ, Weston CJ, Davis ET, Jones SW, Grover LM. Geometric confinement is required for recovery and maintenance of chondrocyte phenotype in alginate. APL bioengineering. Dec. 1, 2017;1(1).
  • Darling EM, Athanasiou KA. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. Journal of orthopaedic research. Mar. 2005;23(2):425-32.
  • Diederichs S, Klampfleuthner FA, Moradi B, Richter W. Chondral differentiation of induced pluripotent stem cells without progression into the endochondral pathway. Frontiers in Cell and Developmental Biology. Nov. 1, 2019;7:270.
  • Duarte Campos DF, Drescher W, Rath B, Tingart M, Fischer H. Supporting biomaterials for articular cartilage repair. Cartilage. Jul. 2012;3(3):205-21.
  • DuRaine GD, Brown WE, Hu JC, Athanasiou KA. Emergence of scaffold-free approaches for tissue engineering musculoskeletal cartilages. Annals of biomedical engineering. Mar. 2015;43:543-54.
  • Finger F, Schörle C, Zien A, Gebhard P, Goldring MB, Aigner T. Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/12. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. Dec. 2003;48(12):3395-403.
  • Forsyth CB, Cole A, Murphy G, Bienias JL, Im HJ, Loeser Jr RF. Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. Sep. 1, 2005;60(9):1118-24.
  • Forsyth CB, Pulai J, Loeser RF. Fibronectin fragments and blocking antibodies to α2β1 and α5β1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis & Rheumatism. Sep. 2002;46(9):2368-76.
  • Giovannini S, Diaz-Romero J, Aigner T, Mainil-Varlet P, Nesic D. Population doublings and percentage of S100-positive cells as predictors of in vitro chondrogenicity of expanded human articular chondrocytes. Journal of cellular physiology. Feb. 2010;222(2):411-20.
  • Hu X, Li D, Gao C. Chemically cross-linked chitosan hydrogel loaded with gelatin for chondrocyte encapsulation. Biotechnology journal. Nov. 2011;6(11):1388-96.
  • Karperien M. Human OA Model Technologies: “Joint-On-A-Chip”. In: OARSI World Congress on Osteoarthritis; May 2-5, 2019; Toronto, Canada; 44 pages.
  • Lin Z, Fitzgerald JB, Xu J, Willers C, Wood D, Grodzinsky AJ, Zheng MH. Gene expression profiles of human chondrocytes during passaged monolayer cultivation. Journal of Orthopaedic Research. Sep. 2008;26(9):1230-7.
  • Lin Z, Li Z, Li EN, Li X, Del Duke CJ, Shen H, Hao T, O'Donnell B, Bunnell BA, Goodman SB, Alexander PG. Osteochondral tissue chip derived from iPSCs: modeling OA pathologies and testing drugs. Frontiers in bioengineering and biotechnology. Dec. 17, 2019;7:411.
  • Meyerink JG, Kota D, Wood ST, Crawford GA. Transparent titanium dioxide nanotubes: processing, characterization, and application in establishing cellular response mechanisms. Acta Biomaterialia. Oct. 1, 2018;79:364-74.
  • Nelson KJ, Bolduc JA, Wu H, Collins JA, Burke EA, Reisz JA, Klomsiri C, Wood ST, Yammani RR, Poole LB, Furdui CM. H2O2 oxidation of cysteine residues in c-Jun N-terminal kinase 2 (JNK2) contributes to redox regulation in human articular chondrocytes. Journal of Biological Chemistry. Oct. 19, 2018;293(42):16376-89.
  • O'Connell GD, Lima EG, Bian L, Chahine NO, Albro MB, Cook JL, Ateshian GA, Hung CT. Toward engineering a biological joint replacement. The journal of knee surgery. Sep. 2012;25(03):187-96.
  • Occhetta P, Mainardi A, Votta E, Vallmajo-Martin Q, Ehrbar M, Martin I, Barbero A, Rasponi M. Hyperphysiological compression of articular cartilage induces an osteoarthritic phenotype in a cartilage-on-a-chip model. Nature biomedical engineering. Jul. 2019;3(7):545-57.
  • Rosser J, Bachmann B, Jordan C, Ribitsch I, Haltmayer E, Gueltekin S, Junttila S, Galik B, Gyenesei A, Haddadi B, Harasek M. Microfluidic nutrient gradient-based three-dimensional chondrocyte culture-on-a-chip as an in vitro equine arthritis model. Materials Today Bio. Sep. 1, 2019;4:100023.
  • Saas J, Gebauer M, Jacobi C, Haag J, Takigawa M, Aigner T. The human chondrosarcoma HCS- 2/8 cell line is responsive to BMP-7, but not to IL-1beta. Front Biosci. Sep. 1, 2005;10:2027-35.
  • Santoro A, Conde J, Scotece M, Abella V, López V, Pino J, Gómez R, Gómez-Reino JJ, Gualillo O. Choosing the right chondrocyte cell line: Focus on nitric oxide. Journal of orthopaedic research. Dec. 2015;33(12):1784-8.
  • Saraswat R, Ratnayake I, Perez EC, Schutz WM, Zhu Z, Ahrenkiel SP, Wood ST. Micropatterned biphasic nanocomposite platform for maintaining chondrocyte morphology. ACS applied materials & interfaces. Mar. 23, 2020;12(13):14814-24.
  • Wood ST, Long DL, Reisz JA, Yammani RR, Burke EA, Klomsiri C, Poole LB, Furdui CM, Loeser RF. Cysteine-mediated redox regulation of cell Signaling in chondrocytes stimulated with fibronectin fragments. Arthritis & rheumatology. Jan. 2016;68(1):117-26.
  • Yin W, Park JI, Loeser RF. Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways. Journal of Biological Chemistry. Nov. 13, 2009;284(46):31972-81.
Patent History
Patent number: D1152071
Type: Grant
Filed: Jul 22, 2024
Date of Patent: Oct 6, 2026
Assignee: SOUTH DAKOTA BOARD OF REGENTS (Pierre, SD)
Inventors: Scott Wood (Rapid City, SD), Bryce L. Deaver (Rapid City, SD), Tierney Robinson (Rapid City, SD), Cody M. Collier (Rapid City, SD)
Primary Examiner: Mary Shannon Malley
Application Number: 29/953,487
Classifications
Current U.S. Class: Specimen Handling, Preparation Or Testing (62) (D24/216)